A novel signature based on microvascular invasion predicts the recurrence of HCC

BACKGROUND AND OBJECTIVES: In hepatocellular carcinoma (HCC) patients, microvascular invasion (MVI) is associated with worse outcomes regardless of treatment. No single reliable preoperative factor exists to predict MVI. The aim of the work described here was to develop a new MVI− based mRNA biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Binbin, Wang, Fang, Jarad, Beers, Wang, Zhihui, Zhang, Yanzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336478/
https://www.ncbi.nlm.nih.gov/pubmed/32631357
http://dx.doi.org/10.1186/s12967-020-02432-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336478/
https://www.ncbi.nlm.nih.gov/pubmed/32631357
http://dx.doi.org/10.1186/s12967-020-02432-7

Ejemplares similares